PROBLEM! The drug companies will never let this get approved.
One thing I don’t understand is why the drug companies haven’t gotten into the stem cell game. If I was a ceo at one of them that would be a no-brainer. Spending huge money now in the adult stem cell game. Then charging whatever they wanted when treatments were developed. Lets just say theyw ouldn’t charge 600$ for something that could cure the heart.. which imo would be huge profit imo. Think you are competing against 250,000$ surgeries.
Maybe its just too early or they are stuck on the pharma model and don’t see themselves as being able to get into a new area. I think they risk being left behind if they don’t make the jump in all honesty. We already are seeing their revenues stagnate. The reality imo from my reading is we have gotten most of the ‘fruit’ to be gotten in the chemical molecule field. And it appears almost all of the low hanging fruit.
The next areas of human health, like adult stem cells, gene therapy promise going way beyond what we can do now. So the drug model seems to be destined to become ‘commoditized’, like it is now with some of their big money makers going off patent. I’ll give them they jumped into biologicals.